Corcept Therapeutics Inc
Change company Symbol lookup
Select an option...
CORT Corcept Therapeutics Inc
HRTX Heron Therapeutics Inc
IFBD Infobird Co Ltd
JACK Jack in the Box Inc
MVLY Mission Valley Bancorp
CLSD Clearside Biomedical Inc
GBRGU Goldenbridge Acquisition Ltd
CHMI-B Cherry Hill Mortgage Investment Corp
KAIIU Kismet Acquisition Two Corp
KITT Nauticus Robotics Inc
Go

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Corcept Therapeutics Incorporated is a commercial-stage company engaged in the discovery and development of drugs that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. It has marketed Korlym (mifepristone) for the treatment of patients suffering from Cushing’s syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, exicorilant, dazucorilant and miricorilant. Its cortisol activity can be modulated by a drug that competes with cortisol as it attempts to bind to the glucocorticoid receptor (GR). The Company’s ingredient, mifepristone, reduces the binding of excess cortisol to GR. Its compounds bind to GR but not the progesterone, estrogen, or androgen receptors.

Closing Price
$25.08
Day's Change
-0.13 (-0.52%)
Bid
--
Ask
--
B/A Size
--
Day's High
25.44
Day's Low
24.85
Volume
(Average)
Volume:
546,853

10-day average volume:
591,217
546,853
  • Prev Close
    25.21
  • Today's Open
    25.42
  • Day's Range
    24.85-25.44
  • Avg Vol (10-day)
    591.2K
  • Last (time)
    4:00p ET 09/23/22
  • Last (size)
    2.4K
  • 52-Wk Range
    15.83 - 29.93
    LowHigh
  • (12/08/21 - 07/27/22)
    16.20%
  • 51.6%
  • Market Cap
    2.7B
  • Shares Outstanding
    107.1M
  • 0.94
  • 26.65x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.6
  • 79.69
  • (% of float 08/31/22)
    18.24

Latest News

September 16, 2022
9:00 pm ET
Globe Newswire
September 11, 2022
9:00 pm ET
Globe Newswire
September 07, 2022
6:20 pm ET
Accesswire
September 06, 2022
9:10 pm ET
Globe Newswire
September 04, 2022
8:16 am ET
Accesswire
August 31, 2022
9:00 pm ET
Globe Newswire
August 26, 2022
9:00 pm ET
Globe Newswire
August 24, 2022
5:48 pm ET
Accesswire
August 21, 2022
9:00 pm ET
Globe Newswire
8:17 am ET
Accesswire
August 15, 2022
9:00 pm ET
Globe Newswire
August 10, 2022
9:00 pm ET
Globe Newswire
5:51 pm ET
Accesswire
August 07, 2022
8:17 am ET
Accesswire
August 05, 2022
9:00 pm ET
Globe Newswire
August 03, 2022
4:05 pm ET
Globe Newswire
August 01, 2022
7:10 am ET
MarketWatch
July 31, 2022
9:01 pm ET
Globe Newswire
July 28, 2022
4:23 pm ET
Globe Newswire
July 27, 2022
5:47 pm ET
Accesswire
July 25, 2022
11:02 pm ET
Globe Newswire
July 22, 2022
8:18 am ET
Accesswire
July 20, 2022
9:00 pm ET
Globe Newswire
July 15, 2022
9:00 pm ET
Globe Newswire
8:17 am ET
Accesswire
July 10, 2022
9:00 pm ET
Globe Newswire
July 06, 2022
5:45 pm ET
Accesswire
July 04, 2022
9:00 pm ET
Globe Newswire
July 03, 2022
8:18 am ET
Accesswire
June 29, 2022
9:00 pm ET
Globe Newswire
4:05 pm ET
Globe Newswire
June 28, 2022
9:01 pm ET
Newsfile
April 05, 2022
11:54 am ET
Zacks
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.